Charter Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
ONB
GIM
Charter Capital Management's LLY Position: Q2 2026 in Review
Charter Capital Management reduced its Eli Lilly (LLY) stake by 2.2% in Q2 2026, selling an estimated $14.3K and leaving 616 shares worth $739K. The position accounts for 0.33% of the portfolio, ranked #26.
Charter Capital Management first reported a position in LLY in Q2 2025 and has held it in 5 quarters since. 1,692 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Charter Capital Management held 616 shares of Eli Lilly worth $739K as of Q2 2026.
- Charter Capital Management sold 14 Eli Lilly shares in Q2 2026, an estimated $14.3K.
- Eli Lilly made up 0.33% of Charter Capital Management's portfolio in Q2 2026, its #26 holding.
- Charter Capital Management first reported a position in Eli Lilly in Q2 2025 and has held it in 5 quarters since.
- 1,692 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Charter Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.